034940 — ChoA Pharmaceutical Co Balance Sheet
0.000.00%
- KR₩28bn
- KR₩49bn
- KR₩59bn
Annual balance sheet for ChoA Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10,214 | 6,996 | 4,415 | 5,472 | 2,532 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 24,932 | 27,623 | 23,908 | 20,971 | 19,943 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 46,504 | 48,200 | 42,157 | 39,740 | 35,052 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 24,074 | 24,999 | 20,370 | 19,712 | 19,067 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 80,512 | 85,639 | 74,221 | 71,320 | 64,683 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 24,263 | 27,328 | 29,178 | 36,656 | 35,759 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 30,592 | 32,796 | 33,228 | 39,944 | 39,678 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 49,920 | 52,844 | 40,993 | 31,376 | 25,005 |
| Total Liabilities & Shareholders' Equity | 80,512 | 85,639 | 74,221 | 71,320 | 64,683 |
| Total Common Shares Outstanding |